MWAI (MedWellAI) 3-Year RORE % : -87.23% (As of Mar. 2026)


MWAI MedWellAI Inc MWAI
6 GF Score
Price $0.29
! 4 Warning Signs
View Full Analysis

What is MedWellAI 3-Year RORE %?

MedWellAI MWAI 6 3-Year RORE % is -87.23 as of Mar. 2026. GuruFocus rates MWAI with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 764 Capital Markets companies, MedWellAI ranks worse than 91.1% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. MedWellAI's 3-Year RORE % for the quarter that ended in Mar. 2026 was -87.23%.

The industry rank for MedWellAI's 3-Year RORE % or its related term are showing as below:

MWAI's 3-Year RORE % is ranked worse than
91.1% of 764 companies
in the Capital Markets industry
Industry Median: 15.115 vs MWAI: -87.23

MedWellAI  (OTCPK:MWAI) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


MedWellAI 3-Year RORE % Related Terms


MedWellAI 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for MedWellAI's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedWellAI 3-Year RORE % Chart

MedWellAI Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.43 -11.34 -19.43 15.72 -70.15

MedWellAI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.92 -70.15 -87.36 -87.94 -87.23

MWAI vs IPST, BTMCQ, LMFA: 3-Year RORE % Comparison

For the Capital Markets subindustry, MedWellAI's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedWellAI 3-Year RORE % vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, MedWellAI's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where MedWellAI's 3-Year RORE % falls into.


MWAI
6GF Score
MedWellAI Inc MWAI
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedWellAI 3-Year RORE % Calculation

MedWellAI's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.38--12.68 )/( -14.1-0 )
=12.3/-14.1
=-87.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -87.23 mean?
MedWellAI (MWAI) has a 3-Year RORE % of -87.23 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MedWellAI and its competitors. According to the industry distribution chart, MedWellAI ranks #696 out of 764 companies in the Capital Markets industry, placing it in the top 91.1%.
Is MedWellAI's 3-Year RORE % too high?
MedWellAI's current 3-Year RORE % is -87.23. Based on the distribution chart, MedWellAI ranks #696 out of 764 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, MedWellAI has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does MedWellAI's 3-Year RORE % compare to IPST and BTMCQ?
According to the Capital Markets industry distribution chart, MedWellAI ranks #696 out of 764 companies for 3-Year RORE %. This places MedWellAI in the lower half of its industry. The industry median 3-Year RORE % is 15.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Capital Markets company?
The median 3-Year RORE % among Capital Markets companies is 15.12, based on 764 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MedWellAI and its competitors. For the Capital Markets industry, the median 3-Year RORE % is 15.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedWellAI's current 3-Year RORE % is -87.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedWellAI stock overvalued right now?
MedWellAI (MWAI) has a current 3-Year RORE % of -87.23. The current 3-Year RORE % is -87.23. MedWellAI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For MedWellAI (MWAI), the current 3-Year RORE % is -87.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedWellAI Business Description

Address 2380 Drew Street, Suite 3, Clearwater, FL, USA, 33765
MedWellAI Inc is a holding company focused on AI-driven healthcare and wellness solutions, offering a B2B platform for GLP medications with real-time inventory and provider support. The company operates as a single operating segment, focusing on acquiring, launching, and operating companies in the rapidly growing health and wellness sector.
6GF Score

Get the complete analysis for MWAI

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price